Mirum Pharmaceuticals, Inc. MIRM Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accounts receivable?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accounts receivable of $133.11M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accounts receivable increased by 38.9% year-over-year, from $95.85M to $133.11M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.